FindTrial
Sign In

Retrospective analysis of therapeutic effect and influencing factors of hyperbaric oxygen therapy for neonatal brain injury

Retrospective Analysis of Neurological Prognosis after Hyperbaric medicine for Neonatal Brain Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073297
Enrollment
Unknown
Registered
2023-07-06
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal brain injury

Interventions

Hyperbaric oxygen treatment group:None
Non-hyperbaric oxygen treatment group:None

Sponsors

Shenzhen Children‘s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1.5 Years to 5.5 Years

Inclusion criteria

Inclusion criteria: 1.From January 2018 to December 2021, newborns hospitalized in our hospital were diagnosed with neonatal brain injury after discharge, including neonatal hypoxic ischemic encephalopathy, neonatal cerebral infarction, neonatal intracranial hemorrhage, hypoglycemic brain injury, and bilirubin encephalopathy. 2. Neurodevelopmental assessments are conducted at birth and at the ages of 3, 6, and 12 months.

Exclusion criteria

Exclusion criteria: 1. Incomplete clinical data of the child; 2.The researchers consider that the child is not suitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Neurodevelopmental prognosis;—

Secondary

MeasureTime frame
Neurological complications;—

Countries

China

Contacts

Public ContactCao Jianguo

Shenzhen Children‘s Hospital

caojgsz@126.com+86 189 3869 1549

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026